Insider Transactions Reported by 16 Insiders of IOVANCE BIOTHERAPEUTICS, INC.

Symbol
IOVA on Nasdaq
Location
San Carlos, CA

Insiders trading volume in the past year

IOVANCE BIOTHERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Wayne P. Rothbaum Director $257,731,097 01 Mar 2024
MERRILL A. MCPEAK Director $5,661,865 01 Mar 2024
Frederick G. Vogt Interim CEO & General Counsel, Director $2,134,298 +$42,250 +2% 09 Mar 2026
Daniel Gordon Kirby Chief Commercial Officer $1,233,660 +$55,200 +4.7% 09 Mar 2026
Iain D. Dukes Director $825,341 13 Jun 2025
Friedrich Graf Finckenstein Chief Medical Officer $721,838 09 Mar 2026
Igor Bilinsky Chief Operating Officer $705,741 09 Mar 2026
Raj K. Puri Chief Regulatory Officer $621,998 +$9,743 +1.6% 09 Mar 2026
Ryan D. Maynard Director $488,116 13 Jun 2025
Jean-Marc Bellemin Chief Financial Officer $485,281 02 Jun 2025
WENDY L. DIXON Director $468,517 10 Jun 2022
Athena Countouriotis Director $412,666 13 Jun 2025
WENDY L. YARNO Director $412,666 13 Jun 2025
Michael Weiser Director $412,666 13 Jun 2025
Matthew William Rosinack SVP, Finance (Int. PFO & PAO) $153,382 30 Jun 2025
Corleen M. Roche Chief Financial Officer 09 Mar 2026

Recent Insider Transactions by Companies or Individuals for IOVANCE BIOTHERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.